Novoprotein Scientific Inc. (SHA:688137)
China · Delayed Price · Currency is CNY 50.00
+0.80 (1.63%)
At close: Jan 23, 2026
Novoprotein Scientific Revenue
Novoprotein Scientific had revenue of 39.76M CNY in the quarter ending September 30, 2025, with 22.63% growth. This brings the company's revenue in the last twelve months to 147.33M, up 9.49% year-over-year. In the year 2024, Novoprotein Scientific had annual revenue of 127.56M, down -16.73%.
Revenue (ttm)
147.33M
Revenue Growth
+9.49%
P/S Ratio
23.68
Revenue / Employee
260.30K
Employees
556
Market Cap
3.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 127.56M | -25.64M | -16.73% |
| Dec 31, 2023 | 153.19M | -111.36M | -42.09% |
| Dec 31, 2022 | 264.55M | -77.34M | -22.62% |
| Dec 31, 2021 | 341.90M | 162.05M | 90.11% |
| Dec 31, 2020 | 179.84M | 143.86M | 399.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Guangdong VTR Bio-Tech | 830.87M |
| Cabio Biotech (Wuhan) | 596.47M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Shanghai Model Organisms Center | 419.09M |
| Yantai Zhenghai Biotechnology | 347.60M |